Vimarsana
Biggest News Aggregation in the World

Page 5 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gamida Cell Today - Breaking & Trending Today

Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript - Vimarsana News

Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Gamida Cell's Conference Call for Third Quarter 2023 Financial Results.

Gamida Cell (GMDA) Set to Announce Quarterly Earnings on Tuesday - Vimarsana News

Gamida Cell (GMDA) Set to Announce Quarterly Earnings on Tuesday

Gamida Cell (NASDAQ:GMDA – Get Free Report) will announce its earnings results before the market opens on Tuesday, November 14th. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Gamida Cell (NASDAQ:GMDA – Get Free […]

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer Annual Meeting - Vimarsana News

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer Annual Meeting

Gamida Cell Ltd. shared new data on the impact of the company?s proprietary nicotinamide technology on its allogeneic stem cell therapy omidubicel and investigational natural killer cell therapy...

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting - Vimarsana News

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

BOSTON, Nov. 04, 2023 -- Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide ...

Gamida Cell Presents New Data on Allogeneic Stem Cell - Vimarsana News

Gamida Cell Presents New Data on Allogeneic Stem Cell

Data further characterize the mechanism for Gamida Cell’s proprietary nicotinamide (NAM) technology’s expansion and enhancement of cells...